Drug Type Small molecule drug |
Synonyms Genetic Epilepsies (Actio) |
Target |
Mechanism KCa4.1 inhibitors(potassium sodium-activated channel subfamily T member 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Actio Biosciences, Inc.Startup |
Active Organization Actio Biosciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Preclinical | US | Actio Biosciences, Inc.Startup | 13 Jul 2024 |